HRMY
Harmony Biosciences Holdings Inc
Price:
35.21
USD
Volume:
653,071
United States | Pharmaceuticals
HRMY Gross Margin
As of 2025-07-17, the Gross Margin of Harmony Biosciences Holdings Inc (HRMY) is 78.1%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
HRMY Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 78.1% |
| 2023-12-31 | 79.2% |
| 2022-12-31 | 80.9% |
| 2021-12-31 | 81.8% |
| 2020-12-31 | 82.7% |
| 2019-12-31 | 73.3% |
| 2018-12-31 | - |
| - | |
| - | |
| - |
HRMY Gross Margin - Peers Comparison